Indivior Pharmaceuticals, Inc. (INDV)
39.68
-0.94
(-2.30%)
USD |
NASDAQ |
May 07, 09:52
Indivior Pharmaceuticals SG&A Expense (TTM) : 627.00M for March 31, 2026
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| ANI Pharmaceuticals, Inc. | 317.74M |
| Catalyst Pharmaceuticals, Inc. | 171.18M |
| Viatris, Inc. | 3.794B |
| Pulse Biosciences, Inc. | 24.30M |
| Revolution Medicines, Inc. | 195.04M |